Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Syndax Pharmaceuticals (SNDX) Return on Sales (2016 - 2021)

Historic Return on Sales for Syndax Pharmaceuticals (SNDX) over the last 7 years, with Q3 2021 value amounting to 52.26%.

  • Syndax Pharmaceuticals' Return on Sales rose 1200.0% to 52.26% in Q3 2021 from the same period last year, while for Sep 2021 it was 52.26%, marking a year-over-year decrease of 89100.0%. This contributed to the annual value of 13.45% for FY2024, which is N/A changed from last year.
  • Syndax Pharmaceuticals' Return on Sales amounted to 52.26% in Q3 2021, which was up 1200.0% from 52.32% recorded in Q2 2021.
  • In the past 5 years, Syndax Pharmaceuticals' Return on Sales ranged from a high of 15.95% in Q4 2017 and a low of 52.38% during Q3 2020
  • Moreover, its 5-year median value for Return on Sales was 47.07% (2018), whereas its average is 44.54%.
  • As far as peak fluctuations go, Syndax Pharmaceuticals' Return on Sales surged by 197000bps in 2017, and later plummeted by -349300bps in 2018.
  • Quarter analysis of 5 years shows Syndax Pharmaceuticals' Return on Sales stood at 15.95% in 2017, then crashed by -219bps to 50.88% in 2018, then grew by 27bps to 37.38% in 2019, then tumbled by -40bps to 52.26% in 2020, then changed by 0bps to 52.26% in 2021.
  • Its Return on Sales stands at 52.26% for Q3 2021, versus 52.32% for Q2 2021 and 49.49% for Q1 2021.